Supportive Care News & Features
This study's information can inform policy issues, particularly the collection of patient-reported outcome data and its use in clinical practice.
Study authors suggest that oncologists and oncology providers can help design effective, personalized workplace accommodations for patients with cancer.
Patients who reported better clinician communication or an improved satisfaction with their treatment were more likely to be adherent.
Interprofessional practice provides benefits to patients, team members, and the health care system, by working collaboratively to support and assist each other.
According to the AACI, proposed budget cuts by the White House would likely mean a cut of close to $1 billion for the National Cancer Institute.
More in Supportive Care
ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.
Inadequate pain management, baseline pain severity linked to pain deterioration
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
A Canadian study has identified factors associated with opioid prescriptions for severe pain in the elderly: younger age, male sex, comorbid illness, type of cancer, and assessment at home, results of a study in the Journal of Clinical Oncology published online February 27 has found.
Intrathecal Therapy Cost-Effective for Patients with Cancer Pain Who Have a Favorable Life-Expectancy
In selected patients with cancer pain on high-cost conventional regimens, intrathecal therapy may become cost-effective as early as seven months following implant, and greater duration of therapy is associated with reduced costs.
The American Society of Clinical Oncology Clinical Practice Guideline on the integration of palliative care into standard oncology care has been updated.
Despite the availability of palliative and supportive care at major cancer centers, patients may encounter barriers to accessing these services.
The early integration of palliative care shortly after diagnosis of some incurable cancers improves both a patient's coping abilities and overall quality of life.
The introduction of palliative care shortly after a patient is diagnosed with cancer is associated with improved quality of life.
Continuous deep sedation (CDS) should be considered a viable option for patients with advanced cancer being cared for in a palliative setting.
Mindfulness meditation practice conducted by patients with CRC at the beginning of chemotherapy infusion decreased cortisol blunting.
The FDA accepted for review a supplemental New Drug Application for ibrutinib as a treatment for chronic graft-versus-host-disease.
This study suggest that nilotinib is associated with higher rates of treatment-induced T2DM and hyperlipidemia compared with dasatinib.
This study indicates that there is no difference in efficacy or safety between aprepitant and fosaprepitant, though the study was limited by its small sample size.
PRT yields similar progression-free survival rates to IMRT; outcomes depend largely on the success of surgery prior to radiation therapy.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- FDA Warns 14 Companies To Stop Selling Illegal Cancer Treatments
- ASCO Releases Opinion on Hormonal Therapy for Castrate-resistant Prostate Cancer
- Bladder Cancer: Immunotherapies, Combination Therapies, and Current Research
- Pembrolizumab for Advanced Melanoma: Efficacy and Toxicity
- Nivolumab Fails as Single-agent Treatment for Advanced Uterine Leiomyosarcoma